Drupal.behaviors.print = function(context) {window.print();window.close();}>
Ventana's Growing Companion Dx Focus Mirrors Parent Roche's Investment in Personalized Rx
January 18, 2012
Ventana's Growing Companion Dx Focus Mirrors Parent Roche's Investment in Personalized Rx
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
During Investor Day, Roche Highlights Personalized Medicine as Key Area for Future Growth
September 12, 2012 / Pharmacogenomics Reporter
PGx Drugs Xalkori, Zelboraf Show Strong Growth in First Quarter of 2013
May 1, 2013 / Pharmacogenomics Reporter
Q&A: Diaceutics CEO Keeling Provides Personalized Rx-Focused Consultant's View of Industry Progress
February 22, 2012 / Pharmacogenomics Reporter
Mayo Study Finds Expanded Protein Panel Fails to Predict Outcome of Herceptin Treatment
December 16, 2011 / ProteoMonitor
FDA Approves HER2 Test for Breast Cancer
June 14, 2011 / GenomeWeb Daily News